Excellence and Collaborative Projects
The following selection highlights excellence and collaborative projects that advance our collective research goals and contribute to impactful developments in the field.
The Center of Excellence for Metaproteomics at the University of Vienna will focus on microbiome research using high-resolution protein-based methods. The strategic partnership between the University of Vienna and Bruker combines cutting-edge research with state-of-the-art technology. The Center of Excellence for Metaproteomics is headed by biochemist David Gómez-Varela, Division of Pharmacology and Toxicology.
Christian Doppler (CD) Laboratories are specialized research units that facilitate high-level application-oriented basic research by bridging the gap between academic institutions and private companies.
CD-Laboratory for Molecular Informatics in the Biosciences (2022-2029); PI: Johannes Kirchmair, Division of Pharmaceutical Chemistry
Since 2007, the European Research Council (ERC) has been awarding grants that give outstanding researchers the opportunity to pursue innovative projects. These grants are awarded in extremely competitive selection rounds.
ERC Consolidator Grant:
CLAR - A calorimeter at atomic resolution (2023-2028); PI: Julien Orts, Division of Pharmaceutical Chemistry
ERC Starting Grant:
GLYCONOISE - Emergent properties of cell surface glycosylation in cell-cell communication (2017 - 2023); PI: Christoph Rademacher, Division of Pharmaceutical Technology and Biopharmaceutics
The main objective of the FWF-doc.funds is to support excellent research training for doctoral students in existing doctoral programs. In the long term, it is intended to contribute to reinforcing research orientation and to consolidating existing education and training structures for highly qualified junior researchers. AIDD brings together a multidisciplinary team of ten internationally recognized principal investigators and ten FWF-funded doctoral fellows.
AIDD-Anti-Infectives Drug Discovery (2025-2030), PI: Judith Rollinger, Division of Pharmacognosy
The MSCA doctoral network is a prestigious EU-funded program designed to train doctoral candidate through international, interdisciplinary, and intersectoral networks. These networks foster collaboration between academia and industry to improve researcher career prospects.
METAMIC 3 - Metaproteome-based leveraged microbiome management in the context of One Health (2025-2029), PI: David Gómez Varela and Manuela Schmidt, Center of Excellence for Metaproteomics, Division of Pharmacology and Toxicology
AUREUS - wAll teichoic acids as immUnogenic and conseRved altErnative targets for therapies versUs S. aureus (2025-2029), PI: Christoph Rademacher, Division of Pharmaceutical Technology
ALLODD - Allostery in Drug Discovery (2021-2025), PI: Christoph Rademacher, Division of Pharmaceutical Technology
AIDD - Advanced Machine Learning for Innovative Drug Discovery (2021-2024), PI: Johannes Kirchmair, Division of Pharmaceutical Chemistry